Novartis Takes Israeli Drugmaker Teva To Court Over Patents
Monday July 28th, 2008 / 16h07
GENEVA (AFP)--Swiss pharmaceutical giant Novartis AG (NVS) said Monday it had filed a lawsuit in the U.S. against Israeli generic drugmaker Teva Pharmaceutical Industries Ltd. (TEVA), over patents for two medications to treat bone diseases. The lawsuit, which was filed Thursday, aims to prevent Teva - the world's largest generic drug company - from selling generic versions of the two drugs, Zometa and Reclast, until their patents expire in 2013, a Novartis spokesman said. The drug company spokesman couldn't say when the U.S. court might reach a decision in the patent case. In the first half of this year, Novartis reported sales of the drug Zometa, which is used to fight bone cancer, at $677 million and Reclast, used to treat post-menopausal osteoporosis, at $103 million. Novartis has already gone before the U.S. courts to fight the introduction of generic versions of its drug Famvir for treating genital herpes and Lotrel for hypertension by Teva. Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/al?rnd=eBcEaH%2BraORqljI2v4M5ww%3D%3D. You can use this link on the day this article is published and the following day.
La Bourse de Paris a tenté un rebond à l'ouverture vendredi, est repassée dans le rouge dix minutes après, pour revenir en territoire positif. Dans le sillage de l'indice...
Les valeurs américaines s'inscrivent toujours en fort recul jeudi avec la publication de mauvais chiffres hebdomadaires de l'emploi et les inquiétudes concernant...
La Bourse de Tokyo a fini en hausse de 2,70% vendredi, se retournant après la mi-journée grâce à des rachats de découverts motivés par l'attente d'un redressement de Wall...
L'euro se replie face au dollar, et le billet vert perd du terrain face au yen après la publication de l'indice américain des prix à la production, qui a...
Le baril de brut léger américain a clôturé jeudi sur le marché Nymex en baisse de 7,46%, sous les 50 dollars le baril, la chute des Bourses ne faisant qu'alimenter la crainte...
